Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Medexus Pharmaceuticals Inc ( (TSE:MDP) ) just unveiled an update.
Medexus Pharmaceuticals Inc. announced the pricing of a $30 million overnight marketed public offering of common shares. The offering, arranged by a syndicate of underwriters led by Raymond James Ltd., aims to raise capital to repay debts and fund general corporate purposes, including business development activities. The closing of the offering is expected around January 31, 2025, subject to customary conditions and Toronto Stock Exchange approval.
More about Medexus Pharmaceuticals Inc
Medexus Pharmaceuticals Inc. operates in the pharmaceutical industry, focusing on the development and commercialization of innovative and high-quality healthcare products. The company is primarily engaged in providing prescription and over-the-counter products, targeting specific therapeutic areas in North America and other selected markets.
YTD Price Performance: 33.33%
Average Trading Volume: 68,383
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: C$121.3M
Learn more about MDP stock on TipRanks’ Stock Analysis page.
